TinySense: The Future of Non-Invasive Potassium Monitoring for CKD & Dialysis Patients

For individuals living with Chronic Kidney Disease (CKD), potassium management isn’t just a number on a lab report—it’s a daily concern that affects safety, comfort, and peace of mind. Potassium levels can shift unexpectedly, and when they do, the consequences can be serious. But what if monitoring potassium didn’t require needles, blood draws, or repeated hospital visits?

Twisynt Technologies Private Limited, a Bengaluru-based medtech innovator founded by Vismaya S, is building exactly that future with TinySense—a wearable designed to monitor potassium continuously and non-invasively.

Why Potassium Control Is Critical in CKD

Potassium plays a major role in keeping the heart, muscles, and nerves functioning properly. Yet for CKD and dialysis patients, even small imbalances can trigger dangerous conditions like hyperkalemia or hypokalemia, often with little or no warning signs.

Potassium can rise or fall due to food choices, medications, dialysis timing, hydration levels, or sudden changes in health. Traditional blood tests catch only a snapshot during a hospital visit—leaving hours or days unmonitored where risk silently builds.

The Problem With Current Monitoring

In today’s standard care:

• Potassium is checked through periodic blood tests.

• CKD and dialysis patients often undergo multiple needle sticks every month.

• Readings represent only a single point in time.

• Dangerous fluctuations may occur between visits.

• Hospital travel, waiting, and cost add extra stress and complexity.

By the time an abnormal lab result is discovered, the patient might already be experiencing symptoms—or approaching a medical emergency.

The Promise of Non-Invasive Potassium Monitoring

Non-invasive potassium monitoring replaces needles with advanced sensors. Instead of drawing blood, a wearable device analyzes patterns in physiological signals and uses intelligent algorithms to estimate potassium levels and trends.

This technology shifts potassium tracking from a clinic-based event to a continuous, at-home experience, giving both patients and doctors a clearer picture of what’s happening throughout the day—not just during appointments.

Meet TinySense: Twisynt’s Breakthrough Wearable

TinySense is being developed as a discreet, comfortable wearable created specifically for CKD and dialysis patients. From its design to its algorithms, every aspect is tailored to kidney health needs.

Twisynt Technologies Private Limited
MSMF, Mazumdar Shaw Medical Center,
Hosur Road, Bommasandra Industrial Area, Bengaluru, Karnataka 560099
Website: www.twisynt.com

Twisynt’s vision is simple yet transformative:
Empower patients with real-time, needle-free potassium insights—anytime, anywhere.

How TinySense Works

TinySense integrates easily into daily life:

• Patients wear it like a small accessory.

• The device continuously collects data on key physiological patterns.

• Advanced algorithms convert this into potassium trend information.

• If levels begin trending toward a risky zone, the device is intended to send alerts.

• Patients can respond early—before complications arise.

Over time, this creates a rich, personalized potassium profile that helps care teams tailor treatment with greater accuracy.

Benefits for Patients

1. No Needles, No Stress

TinySense minimizes the need for frequent blood draws, reducing discomfort and anxiety.

2. More Control Between Dialysis or Lab Visits

Instead of guessing how diet or medication affects potassium, patients can see real-time patterns.

3. Early Detection of Imbalances

Continuous monitoring can identify rising or falling trends long before symptoms appear.

4. Reduced Emergency Risks

By catching issues early, patients can avoid unexpected hospitalizations, ICU stays, or cardiac events.

Benefits for Clinicians

• Access to continuous potassium data instead of occasional lab reports

• Ability to observe patient-specific trends over days and weeks

• Faster interventions when alerts indicate abnormal movement

• Support for personalized dialysis plans, medication adjustments, and dietary recommendations

• Better overall management of high-risk patients

This data-driven approach supports safer outcomes and enhances the quality of care.

Who Stands to Benefit?

TinySense is being designed for:

• Early-stage to advanced CKD patients

• Hemodialysis and peritoneal dialysis patients

• Individuals with fluctuating potassium levels

• Patients on medications that elevate hyperkalemia risk

• Those with cardiac conditions sensitive to potassium changes

Anyone whose potassium levels shift rapidly—or unpredictably—can benefit from continuous monitoring.

A New Way of Living With CKD

Managing CKD often feels like living from one lab result to the next. TinySense aims to shift this experience from reactive to proactive. When patients can see how their potassium moves throughout the day, they become more confident and informed in managing food, lifestyle, and medications.

This awareness not only lowers anxiety but also encourages better doctor–patient communication and shared decision-making.

Why Twisynt’s Approach Is Different

Twisynt Technologies is uniquely focused on kidney care innovation. With Bengaluru’s strong medtech ecosystem as its foundation, the company is committed to:

• Clinical relevance

• Real-world usability

• Affordability

• Accessibility across urban and rural India

TinySense is being built from the ground up for CKD patients—not adapted from other wearables—making it a more targeted and meaningful solution.

Looking Ahead

Non-invasive potassium monitoring is poised to become a vital part of kidney care in the years ahead. If you or your loved one manages CKD or undergoes dialysis, discussing upcoming monitoring technologies with your nephrologist can help you prepare for safer, smarter care options as they emerge.

To explore more about TinySense and Twisynt’s work, visit www.twisynt.com and stay updated as the technology advances toward real-world use.